Investors Page
MemoryDriver
Now Live
Backed by Rigorous Science. Validated by $15M in NIH Funding
Since 2018, Evon Medics has secured nearly $15 million in highly competitive, non-dilutive funding from the National Institutes of Health (NIH). This robust institutional backing validates our foundational science and significantly de-risks our pathway to commercialization.
Powered by Leading Minds in Neuroscience and Technology.
Leadership
Advisors
Evaristus Nwulia, MD
Co-Founder & Chief Scientific Officer
Charles Nwaokobia, MBA
President
Vamsi Reddy, MSc
Global Head of Product Development
Isioma Udeozo, MBA
CEO, Evon Medics R&D Nigeria
Sebastian Seiguer, JD, MBA
CEO, Scene Health
Sumeet Seth, MBA
CEO, Trulogik